Patents
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
12/2011
12/01/2011US20110293633 Preparation useful for, and method for treatment of neonatal alloimmune thrombocytopenic purpura (nait)
12/01/2011US20110293632 Polypeptide variants with altered effector function
12/01/2011US20110293630 Antibodies to Human GDF8
12/01/2011US20110293624 Genes of an Otitis Media Isolate of NonTypeable Haemophilus Influenzae
12/01/2011US20110293622 Antibodies to il-6 and use thereof
12/01/2011US20110293621 Immunogenic polypeptides comprising a scaffold polypeptide and a l2 polypeptide or a fragment thereof
12/01/2011US20110293620 Monoclonal Antibodies For Use In Diagnosis and Therapy of Cancers and Autoimmune Disease
12/01/2011US20110293619 CROSS-SPECIES-SPECIFIC PSMAxCD3 BISPECIFIC SINGLE CHAIN ANTIBODY
12/01/2011US20110293618 Anti-human clcp1 antibody and use thereof
12/01/2011US20110293617 Anti-p-selectin antibodies and methods of their use and identification
12/01/2011US20110293616 Antigen-presenting complex-binding compositions and uses thereof
12/01/2011US20110293614 Isoform specific anti-her4 antibodies
12/01/2011US20110293613 Bispecific antibodies
12/01/2011US20110293610 Antibodies that immunospecifically bind to b lymphocyte stimulator protein
12/01/2011US20110293609 Antibody Glycosylation Variants Having Increased Antibody-Dependent Cellular Cytotoxicity
12/01/2011US20110293607 Antibody Variants Having Modifications In The Constant Region
12/01/2011US20110293606 Antitumor combinations containing antibodies recognizing specifically cd38 and vincristine
12/01/2011US20110293603 Amino acid sequences directed against multitarget scavenger receptors and polypeptides
12/01/2011US20110293602 Vegf-like factor antibodies and methods of use thereof
12/01/2011US20110293598 Method to produce an immunoglobulin preparation with improved yield
12/01/2011CA2800785A1 Monoclonal antibodies against her2
12/01/2011CA2800769A1 Monoclonal antibodies against her2 epitope
12/01/2011CA2800581A1 Antibodies to human gdf8
12/01/2011CA2800535A1 Class i mhc phosphopeptides for cancer immunotherapy and diagnosis
12/01/2011CA2800488A1 Single -chain variable fragment anti-cd133 antibodies and uses thereof
12/01/2011CA2800272A1 Removal of serine proteases by treatment with finely divided silicon dioxide
12/01/2011CA2800155A1 Method for preparing an enriched igg composition from plasma
12/01/2011CA2799915A1 Methods of purifying polypeptides
12/01/2011CA2799595A1 Method for preparing antibodies having improved properties
12/01/2011CA2799136A1 Vaccine against streptococcal infections based on recombinant proteins
11/2011
11/30/2011EP2390808A2 System and method for identifying complex replikin patterns of amino acids
11/30/2011EP2390807A2 System and method for identifying complex replikin patterns of amino acids
11/30/2011EP2390806A2 System and method for identifying complex replikin patterns of amino acids
11/30/2011EP2390805A2 System and method for identifying complex replikin patterns of amino acids
11/30/2011EP2390804A2 System and method for identifying complex patterns of amino acids
11/30/2011EP2390665A1 Prostate cancer biomarkers
11/30/2011EP2390332A1 Cloning and exploitation of a functional R-gene from Solanum x edinense
11/30/2011EP2390270A1 Therapeutic polypeptides, homologues thereof, fragments thereof and for use in modulating platelet-mediated aggregation
11/30/2011EP2390269A1 Neoplasm specific antibodies and uses thereof
11/30/2011EP2390268A1 Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor
11/30/2011EP2390267A1 Stable and soluble antibodies inhibiting TNF(alpha)
11/30/2011EP2389954A1 Cytotoxic antibodies directed against factor VIII inhibitor antibodies
11/30/2011EP2389953A1 Method of inhibiting receptor tyrosine kinases with an extracellular antagonist and an intracellular antagonist
11/30/2011EP2389951A1 Anti-tumor cell antigen antibody therapeutics
11/30/2011EP2389950A1 Anti-tumor cell antigen antibody therapeutics
11/30/2011EP2389949A1 Anti-tumor cell antigen antibody therapeutics
11/30/2011EP2389948A1 Anti-tumor cell antigen antibody therapeutics
11/30/2011EP2389947A1 Anti-tumor cell antigen antibody therapeutics
11/30/2011EP2389946A1 Anti-tumor cell antigen antibody therapeutics
11/30/2011EP2389943A1 Use of IL-174 antagonists for treating Th2-related diseases
11/30/2011EP2389394A2 Pta089 protein
11/30/2011EP2389393A1 Anti-cd 160 monoclonal antibodies and uses thereof
11/30/2011EP2389392A1 Methods for producing mixtures of antibodies
11/30/2011EP2389386A1 Affinity chromatography matrix
11/30/2011EP2389195A1 Antibody mediated osseous regeneration
11/30/2011EP2389192A2 Stabilized fc polypeptides with reduced effector function and methods of use
11/30/2011EP1924604B1 Human monoclonal antibodies that specifically bind igf-ii
11/30/2011EP1802658B1 Chimeric and humanised monoclonal antibodies against interleukin-13
11/30/2011EP1751192B1 Cross-linked antibodies
11/30/2011EP1585966B1 Treatment of cancer with the anti-ErbB2 antibody rhuMAb 2C4
11/30/2011EP1503799B1 Immunogenic, monoclonal antibody
11/30/2011EP1392360B1 Modified antibodies to prostate-specific membrane antigen and uses thereof
11/30/2011CN1878794B Ngf拮抗剂和阿片样药剂在治疗疼痛中的用途 Ngf antagonist and an opioid agent in the treatment of pain in use
11/30/2011CN1849138B 作为选择性ngf途径抑制剂的人抗ngf中和抗体 Ngf pathway inhibitors as selective human anti ngf neutralizing antibodies
11/30/2011CN102265161A 碱性富含脯氨酸泪基因产物如opiorphin作为生物标志的用途 Basic proline-rich gene products such as tears opiorphin use as biomarkers
11/30/2011CN102264900A 用于切割修饰的dna的组合物、方法和相关用途 The composition for cutting modified dna, methods and related purposes
11/30/2011CN102264896A 抗人流感病毒人型抗体 Human anti-human influenza virus antibodies
11/30/2011CN102264765A 抗muc1抗体 Antibody anti muc1
11/30/2011CN102264764A 抗体 Antibody
11/30/2011CN102264763A 定向于dll4的抗体及其用途 Directed antibodies and their use in dll4
11/30/2011CN102264762A 人抗pd-1、pd-l1和pd-l2的抗体及其应用 Human anti-pd-1, pd-l1 and pd-l2 antibodies and Applications
11/30/2011CN102264759A 与蛋白a的结合改变的免疫球蛋白变体 With a protein A binding altered immunoglobulin variants
11/30/2011CN102264394A 脂化咪唑并喹啉衍生物 Lipidated imidazoquinoline derivative
11/30/2011CN102264393A 作为治疗和预防hcv感染药物的抗hcv单克隆抗体 As the treatment and prevention of drug resistance hcv hcv infection monoclonal antibodies
11/30/2011CN102264392A 免疫球蛋白纯化 Immunoglobulin purification
11/30/2011CN102264390A Il6免疫治疗 Il6 immunotherapy
11/30/2011CN102260915A 制备和构建抗各种呼吸道病毒感染的重大创新性Ab<sub>2</sub>β抗体库的方法 Methods and build anti-respiratory virus infection in a variety of major innovative Ab <sub> 2 </ sub> β antibody library preparation
11/30/2011CN102260648A 重组鼠骨髓瘤细胞ns0-f10及其应用 Recombinant murine myeloma cells and its application ns0-f10
11/30/2011CN102260350A 人鼠嵌合型抗人CD14抗体Hm2F9及用途 Human-mouse chimeric anti-human CD14 antibodies and uses Hm2F9
11/30/2011CN102260349A 用于治疗和预防阿尔茨海默病的抗Aβ31-35抗体及其制备方法 Anti Aβ31-35 antibody treatment and prevention of Alzheimer's disease and its preparation method
11/30/2011CN102260347A 用于多种重金属的抗原的合成及其应用方法 Synthesis and Application of the method used for a variety of heavy metals antigens
11/30/2011CN102260325A Antibacterial peptide NX-16, and preparation method and application thereof
11/30/2011CN102260322A 幽门螺杆菌抗原肽及其应用 Helicobacter pylori antigen peptide and its application
11/30/2011CN102258784A 用于预防和治疗败血症的方法与组合物 For the prevention and treatment of sepsis methods and compositions
11/30/2011CN101580537B 一种人巨细胞病毒ul49基因抗原肽、及其抗体与应用 A human cytomegalovirus gene ul49 antigen peptide, and antibody and application
11/30/2011CN101544965B 从猪胎盘中提取多种生物活性物质的联产工艺 Extracted from pig placenta in a variety of biologically active substances cogeneration process
11/30/2011CN101392022B 葎草花粉主要致敏蛋白单克隆抗体 Humulus pollen major allergens monoclonal antibody
11/30/2011CN101311191B 抗人淋巴细胞免疫球蛋白的制备方法 Anti-human lymphocyte immune globulin preparation
11/30/2011CN101215323B 人ad7c-ntp抗原决定簇多肽、抗体及其在诊断试剂盒上的应用 People ad7c-ntp epitope peptides, antibodies and their use in the diagnosis kit
11/29/2011US8067581 Biomolecules having multiple attachment moieties for binding to a substrate surface
11/29/2011US8067564 Methods of obtaining a specific binding member that binds eotaxin
11/29/2011US8067560 SRSV detection kit
11/29/2011US8067550 Hybridomas producing antibodies against non functional P2X7 receptor
11/29/2011US8067549 Humanized antibodies and compositions for binding sphingosine-1-phosphate
11/29/2011US8067546 Humanized anti-CD70 binding agents and uses thereof
11/29/2011US8067545 Isolated antibodies against biologically active leptin-related peptides
11/29/2011US8067544 anticarcinogenic agents; antiproliferative agent; monoclonal, chimeric and/or fully human antibodies
11/29/2011US8067542 Amino acid sequence variant alfalfa antifungal protein and its use in plant disease control
11/29/2011US8067539 g-protein coupled receptor used in identifying modulators which improve palatability of low-calorie beverages through development of new artificial sweeteners; modulating taste perception
11/29/2011US8067538 Gene related to growth promoting function of acetic acid bacterium, acetic acid bacterium bred using the gene and method for producing vinegar using the acetic acid bacterium